Category | Pharma

Lilly snags rights to Erbitux from BMS

Posted on 20 April 2015

Eli Lilly and Bristol-Myers Squibb announced that the companies have agreed to transfer rights to Erbitux (cetuximab) in North America

Tags: , , ,

Ventana and Astellas in automated tissue diagnostics pact

Posted on 15 April 2015

Ventana Medical Systems has entered into master collaboration agreement with Astellas Pharma to develop novel automated tissue diagnostics

Tags: , ,

Janssen and Ichor Medical enter hep B vaccine delivery alliance

Posted on 14 April 2015

Ichor Medical Systems has entered into a product development collaboration and worldwide license agreement with Janssen Pharmaceuticals

Tags: , , ,

Boehringer Ingelheim partners with Hydra Biosciences for small-molecule TRP inhibitors

Posted on 14 April 2015

Hydra Biosciences and Boehringer Ingelheim have entered into a worldwide research collaboration and license agreement to identify small-molecule TRP inhibitors

Tags: , ,

AstraZeneca partners with PatientsLikeMe

Posted on 14 April 2015

PatientsLikeMe and AstraZeneca have signed a five-year agreement to provide access to PatientsLikeMe’s global network in support of AstraZeneca’s patient-driven research initiatives

Tags: , ,

BioXcel and Takeda in repurposing pact for rare diseases

Posted on 13 April 2015

BioXcel has entered into a partnership with Takeda Development Center Americas for the repurposing of assets across the gamut of rare diseases

Tags: , ,

Mylan bids $29bn for Perrigo

Posted on 13 April 2015

Mylan has made a proposal to acquire Perrigo in a cash-and-stock transaction that would create a diversified, global pharmaceutical leader

Tags:

Merck and Arvinas in therapy alliance using Protac technology

Posted on 09 April 2015

Arvinas announced a strategic collaboration with Merck in which Arvinas’ novel PROTAC technology will be used to degrade target proteins, with the goal of creating novel therapeutics

Tags: , ,

BMS and UniQure in $1bn gene therapy pact

Posted on 07 April 2015

Agreement provides Bristol-Myers Squibb with exclusive access to uniQure’s gene therapy technology platform for multiple targets in cardiovascular diseases

Tags: , ,

Merck and Syndax partner for cancer combo clinical

Posted on 01 April 2015

Syndax and Merck have entered into a clinical trial collaboration to evaluate the safety and efficacy of combining entinostat, an investigational epigenetic therapy, with KEYTRUDA

Tags: , ,